Prevalence of multidrug resistant Mycobacterium tuberculosis in Lucknow, Uttar Pradesh

Indian Journal of Medical Research

Volumn 128, Issue 3, 2008, Pages 300-306

  Jain, Amita ^a   Mondal, Rajesh ^a   Prasad, Rajendra ^a   Singh, Kamlesh ^a   Ahuja, R C ^a  

^a KING GEORGE'S MEDICAL UNIVERSITY   (India)

Author keywords

Multi drug resistance; Mycobacterium tuberculosis; RAPD; Transmission

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADOLESCENT; ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL TRANSMISSION; BACTERIUM CULTURE; BACTERIUM ISOLATE; CONTROLLED STUDY; CULTURE MEDIUM; ENVIRONMENTAL SANITATION; FEMALE; GENE SEQUENCE; GENOTYPE; HEALTH CARE FACILITY; HUMAN; INDIA; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; POPULATION DENSITY; PREVALENCE; RANDOM AMPLIFIED POLYMORPHIC DNA; SCHOOL CHILD; SPUTUM ANALYSIS;

ADOLESCENT; ADULT; CHILD; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; FEMALE; HUMANS; INDIA; MALE; MIDDLE AGED; MYCOBACTERIUM TUBERCULOSIS; PREVALENCE; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RISK FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 58549107030     PISSN: 09715916     EISSN: 09715916     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Heifets LB, Cangelosi GA. Drug susceptibility testing of Mycobacterium tuberculosis: a neglected problem at the turn of the century. Int J Tuberc Lung Dis 1999; 3: 564-81.
2. Farmer P, Furin J, Bayona M, Becerra M, Henry C, Hiatt H, et al. Management of MDR-TB in resource-poor countries. Int J Tuberc Lung Dis 1999; 3: 643-5.
3. Pablos-Mendez A. Working alliance for TB drug development, Cape Town, South Africa, February 8th, 2000. Int J Tuberc Lung Dis 2000; 4: 489-90.
4. Bloom BR, Murray CJ. Tuberculosis: commentary on a reemergent killer. Science 1992; 257: 1055-64.
5. World Health Organization, 2004. The WHO/IUATLD, Global project on antituberculosis drug resistance surveillance 1999-2002. World Health Organization, Geneva, Switzerland.
6. Narayanan S. Molecular epidemiology of tuberculosis. Indian J Med Res 2004; 120: 233-47.
7. World Health Organization, Geneva. WHO report on tuberculosis. WHO/ HTM/STB/factsheet/104/2006. p.1-4.
8. Revised National Tuberculosis Control Programme (RNTCP). Manual for laboratory technician. New Delhi: Central TB Division, Directorate General of Health Services, Ministry of Health and Family Welfare.
9. Petroff SA. A new and rapid method for the isolation and cultivation of tubercle bacilli directly from the sputum and feces. J Exp Med 1915; 21: 38-42.
10. Kubica GP. Differential identification of mycobacteria. VII. key to features for identification of clinically significant mycobacteria. Am Rev Respir Dis 1973; 107: 9-21.
11. Canetti G, Fox W, Khomenko A. Advances in techniques of testing mycobacterial drug sensitivity and the use of sensitivity tests in tuberculosis control programmes. Bull World Health Organ 1969: 41: 21-43.
12. Jain A, Tiwari V, Guleria RS, Verma RK. Qualitative evaluation of mycobacterial DNA extraction protocols for polymerase chain reaction. Mol Biol Today 2002; 3: 43-50.
13. Linton CJ, Jalal H, Leeming PJ, Millar MR. Rapid discrimination of Mycobacterium tuberculosis strains by random amplified polymorphic DNA analysis. J Clin Microbiol 1994; 32: 2169-74.
14. Yates MD, Drobniewski FA, Wilson SM. Evaluation of a rapid PCR-based epidemiological typing method for routine studies of Mycobacterium tuberculosis. J Clin Microbiol 2002; 40: 712-4.
15. Choudhary PR, Tanveer H, Dixit GP. Identification and detection of genetic relatedness among important varieties of pea (Pisum sativum L.) grown in India. Genetica 2007; 130: 183-91.
16. Cohn DL, Bustreo F, Raviglione MC. Drug-resistant tuberculosis; review of the world-wide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease. Clin Infect Dis 1997; 24 (Suppl 1): S121-30.
17. Prasad R. Current MDR status. Indian J Tuberc 2005; 52: 121-31.
18. Sophia V, Balasangameshwara VH, Jagannatha PS, Kumar P. Initial drug resistance among tuberculosis patients under DOTS programme in Bangalore city. Indian J Tuberc 2004; 51: 17-21.
19. Trivedi SS, Desai SG. Primary antituberculosis drug resistance and acquired rifampicin resistance in Gujarat, India. Tubercle 1988; 69: 37-42.
20. Paramasivan CN, Venkataraman P, Chandrasekaran V, Bhat S, Narayanan PR. Surveillance of drug resistance in tuberculosis in two districts of South India. Int J Tuberc Lung Dis 2002; 6: 479-84.
21. Paramasivan CN, Venkataraman P. Drug resistance in tuberculosis in India. Indian J Med Res 2004; 120: 377-86.
22. Lutfey M, Della-Latta PL, Kapur V, Palumbo LA, Gurner D, Stotzky G, et al. Independent origin of mono-rifampin-resistant Mycobacterium tuberculosis in patients with AIDS. Am J Respir Crit Care Med 1996; 153: 837-40.
23. Alland D, Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med 1994; 330: 1710-6.
24. Bifani P, Mathema B, Campo M, Moghazeh S, Nivin B, Shashkina E, et al. Molecular identification of streptomycin monoresistant Mycobacterium tuberculosis related to multidrug-resistant W strain. Emerg Infect Dis 2001; 7: 842-8.
25. Bifani PJ, Plikaytis BB, Kapur V, Stockbauer K, Pan X, Lutfey ML, et al. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 1996; 275: 452-7.
26. Xu, C, Kreiswirth BN, Sreevatsan S, Musser JM, Drlica K. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis. J Infect Dis 1996; 174: 1127-30.
27. Narayanan S, Das S, Garg R, Hari L, Rao VB, Frieden TR, et al. Molecular epidemiology of tuberculosis in a rural area of high prevalence in South India: implications for disease control and prevention. J Clin Microbiol 2002; 40: 4785-8.